References
- Hogness JR, Van Antwerp M. The Artificial Heart. Institute of Medicine National Academy Press, Washington DC, USA (1991).
- Guyton RA, Schonberger JP, Everts PA et al. Postcardiotomy shock: clinical evaluation of the BVS 5000 Biventricular Support System. Ann. Thorac. Surg.56(2), 346–356 (1993).
- Pennington DG, Swartz MT, Lohmann DP, McBride LR. Cardiac assist devices. Surg. Clin. N. Am.78(5), 691–704 (1998).
- Frazier OH, Rose EA, Oz MC et al. Improved mortality and rehabilitation of transplant candidates treated with long-term implantable left ventricular assist system. Ann. Surg.222(3), 327–336; discussion 336–338 (1995).
- Catanese KA, Goldstein DI, Williams DL et al. Outpatient left ventricular assist device support. Ann. Thorac. Surg.62(3), 646–652; discussion 653 (1996).
- Rose EA, Gellins AC, Moskowitz AJ et al. Long-term use of a left ventricular assist device for end-stage heart failure. N. Engl. J. Med.345, 1435 (2001).
- Copeland JG, Smith RG, Arabia FA et al. Cardiac replacement with a total artificial heart as a bridge to transplantation. N. Engl. J. Med.351(9), 859–867 (2004).
- Abiomed BVS Worldwide Registry. Abiomed Cardiovascular Inc., MA, USA (2000).
- Stevenson LW, Kormos RL. Mechanical Cardiac Support 2000. JACC37, 340–370 (2001).
- Baldwin JT, Borovetz HS, Duncan BW et al. The National Heart, Lung and Blood Institute Pediatric Ciculatory Support program. Circulation113, 147 (2006).
- Freedman B. Equipoise and the ethics of clinical research. N. Engl. J. Med.317(3), 141–145(1987).
Patent
- Federal Register. 43 FR 32988. Washington DC. Govt Printing Office, USA.
Websites
- Willman VL. Expert panel review of the NHLBI total artificial heart program www.nhlbi.nih.gov/resources/docs/ tah-rpt.htm.1999
- FDA advisory panel for Abiocor Implantable Replacement Heart www.fda.gov/cdrh/pma/pma2005
- Least burdensome provisions of the FDA Modenization Act of1997 www.fda.gov/cdrh/ode/guidance/1332.pdf
- Interagency Registry for Mechanically Assisted Circulatory Support www.intermacs.org